These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35279598)

  • 1. Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma.
    Yuan H; Wu Y; Wang J; Qin X; Huang Y; Yan L; Fana Y; Zedenius J; Juhlin CC; Larsson C; Lui WO; Xu D
    Biomed Pharmacother; 2022 May; 149():112796. PubMed ID: 35279598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
    Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
    Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
    Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
    Endocr Relat Cancer; 2014 Jun; 21(3):427-34. PubMed ID: 24803525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
    Pereira SS; Máximo V; Coelho R; Batista R; Soares P; Guerreiro SG; Sobrinho-Simões M; Monteiro MP; Pignatelli D
    J Cell Biochem; 2017 Aug; 118(8):2064-2071. PubMed ID: 27886397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas.
    Gupta S; Won H; Chadalavada K; Nanjangud GJ; Chen YB; Al-Ahmadie HA; Fine SW; Sirintrapun SJ; Strong VE; Raj N; Lagunes DR; Vanderbilt CM; Berger MF; Ladanyi M; Dogan S; Tickoo SK; Reuter VE; Gopalan A
    Endocr Pathol; 2022 Jun; 33(2):304-314. PubMed ID: 34549366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis.
    Kannengiesser C; Borie R; Ménard C; Réocreux M; Nitschké P; Gazal S; Mal H; Taillé C; Cadranel J; Nunes H; Valeyre D; Cordier JF; Callebaut I; Boileau C; Cottin V; Grandchamp B; Revy P; Crestani B
    Eur Respir J; 2015 Aug; 46(2):474-85. PubMed ID: 26022962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
    Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
    Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome.
    Deng Z; Glousker G; Molczan A; Fox AJ; Lamm N; Dheekollu J; Weizman OE; Schertzer M; Wang Z; Vladimirova O; Schug J; Aker M; Londoño-Vallejo A; Kaestner KH; Lieberman PM; Tzfati Y
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3408-16. PubMed ID: 23959892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
    Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
    Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Arabidopsis thaliana homolog of the helicase RTEL1 plays multiple roles in preserving genome stability.
    Recker J; Knoll A; Puchta H
    Plant Cell; 2014 Dec; 26(12):4889-902. PubMed ID: 25516598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator of telomere elongation helicase 1 gene and its association with malignancy.
    Hassani MA; Murid J; Yan J
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1735. PubMed ID: 36253342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma.
    Jendrzejewski J; Tomsic J; Lozanski G; Labanowska J; He H; Liyanarachchi S; Nagy R; Ringel MD; Kloos RT; Heerema NA; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1876-80. PubMed ID: 21900378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
    Zhang Y; Calado R; Rao M; Hong JA; Meeker AK; Dumitriu B; Atay S; McCormick PJ; Garfield SH; Wangsa D; Padilla-Nash HM; Burkett S; Zhang M; Kunst TF; Peterson NR; Xi S; Inchauste S; Altorki NK; Casson AG; Beer DG; Harris CC; Ried T; Young NS; Schrump DS
    PLoS One; 2014; 9(7):e101010. PubMed ID: 24983628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of the helicase RTEL1 at telomeres and beyond.
    Hourvitz N; Awad A; Tzfati Y
    Trends Cell Biol; 2024 Feb; 34(2):109-121. PubMed ID: 37532653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis.
    Ley B; Torgerson DG; Oldham JM; Adegunsoye A; Liu S; Li J; Elicker BM; Henry TS; Golden JA; Jones KD; Dressen A; Yaspan BL; Arron JR; Noth I; Hoffmann TJ; Wolters PJ
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1154-1163. PubMed ID: 31268371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.